Stock Movers Hims & Hers Falls, Kroger Rises, Monday.com Sinks on Weak Forecast
Feb 9, 2026
Norma Linda, Bloomberg Television markets correspondent who analyzes notable stock moves. She covers Novo Nordisk suing Hims & Hers over alleged copycat obesity drugs. She explains Kroger’s stock pop after naming a new CEO and resetting guidance. She also discusses Monday.com’s weak revenue forecast and the risks to seat-based software models.
AI Snips
Chapters
Transcript
Episode notes
Legal Risk Crushes Copycat Drug Stocks
- HIMS shares plunged over 20% after Novo Nordisk sued for knockoffs of its obesity medicines.
- Norma Linda highlights the legal risk can hit small competitors while boosting the original maker's stock.
Regulatory Scrutiny Forces Product Pullbacks
- Hims & Hers had already abandoned plans to sell a copycat Wegovy pill amid government scrutiny.
- Norma Linda notes that regulatory pressure can force product rollbacks even before litigation resolves.
New CEO Sparks Kroger Rally
- Kroger shares jumped as much as 8.4% after naming Greg Foran CEO and reinstating 2025 guidance.
- Norma Linda says Foran's Walmart track record reassures investors about Kroger's reset after merger failure.